Neoadjuvant radiotherapy (N-RT) for intracebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial

被引：0
|
作者：
Diehl, C. [1 ,2 ]
Shiban, E. [3 ]
Straube, C. [1 ,2 ]
Oechsner, M. [1 ]
Kessel, C. [1 ]
Wilkens, J. J. [1 ]
Wiestler, B. [4 ]
Zimmer, C. [4 ]
Meyer, B. [3 ]
Combs, S. E. [1 ,2 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Klin Radioonkol, Munich, Germany
[2] Helmholtz Zentrum Munich, Inst Innovat Radiotherapie iRT, Neuherberg, Germany
[3] Tech Univ Munich, Klin Neurochirurg, Klinikum Rechts Isar, Munich, Germany
[4] Tech Univ Munich, Inst Neuroradiol, Klinikum Rechts Isar, Munich, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2019年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P15-4-jD
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial
    Diehl, Christian D.
    Shiban, Ehab
    Straube, Christoph
    Gempt, Jens
    Wilkens, Jan J.
    Oechsner, Markus
    Kessel, Carmen
    Zimmer, Claus
    Wiestler, Benedict
    Meyer, Bernhard
    Combs, Stephanie E.
    CANCER COMMUNICATIONS, 2019, 39 (01):
  • [2] Phase I dose escalation trial of pegzilarginase in patients with advanced solid tumors
    Rasco, Drew W.
    Eckhardt, S. Gail
    Davar, Diwakar
    Lewis, Karl
    Lara-Guerra, Humberto
    Alters, Susan E.
    Eckert, Stephen
    Rowlinson, Scott W.
    Wooldridge, James E.
    Carvajal, Richard D.
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Phase I trial of fruquintinib in patients with advanced solid tumors; Results of the dose escalation phase
    Wang-Gillam, A.
    Yeckes-Rodin, H.
    Kosmo, M. A.
    Stanton, T.
    Park, H.
    Songhua, F.
    Sauter, N. P.
    Kania, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 175 - +
  • [4] Phase I dose escalation trial of image guided stereotactic body radiotherapy for lung tumors
    Feigenberg, S. J.
    Sharma, N.
    Wang, L.
    Cohen, R.
    Buyyounouski, M.
    Lally, B.
    Movsas, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S114 - S114
  • [5] Phase I dose escalation trial of biweekly pemetrexed in combination with docetaxel in advanced solid tumors
    Garland, L. L.
    Cranmer, L., III
    Gerstner, G.
    Walker, R.
    Obregon, Y.
    Ebbinghaus, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Final report of a phase I Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) for lung tumors
    Feigenberg, Steven Joel
    Sharma, Navesh
    Yu, Jian Q.
    Buyyounouski, Mark
    Borghaei, Hossein
    Scott, Walter
    Simon, George
    Unger, Michael
    Movsas, Benjamin
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S943 - S943
  • [7] Phase I dose escalation trial of nintedanib in combination with pembrolizumab in patients with advanced solid tumors (PEMBIB trial)
    Baldini, C.
    Danlos, F-X.
    Varga, A.
    Halse, H.
    Mouraud, S.
    Cassard, L.
    Bredel, D.
    Escriou, G.
    Parpaleix, A.
    Rafie, S.
    Abbassi, A. E.
    Laghouati, S.
    Farhane, S.
    Tselikas, L.
    Texier, M.
    Adam, J.
    Chaput, N.
    Soria, J-C.
    Massard, C.
    Marabelle, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S842 - S843
  • [8] DOSE ESCALATION FOR NEOADJUVANT STEREOTACTIC RADIOSURGERY FOR LARGE BRAIN METASTASES: PHASE I RESULTS
    Murphy, Erin
    Yang, Kailin
    Suh, John
    Yu, Jennifer
    Stevens, Glen
    Angelov, Lilyana
    Vogelbaum, Michael A.
    Barnett, Gene
    Ahluwalia, Manmeet
    Neyman, Gennady
    Mohammadi, Alireza
    Chao, Samuel
    NEURO-ONCOLOGY, 2023, 25
  • [9] Prospective Phase I Dose Escalation Study for Neoadjuvant Radiosurgery for Large Brain Metastases
    Murphy, E. S.
    Yang, K.
    Suh, J. H.
    Yu, J. S.
    Schilero, C.
    Mohammadi, A. M.
    Stevens, G.
    Angelov, L.
    Vogelbaum, M. A.
    Barnett, G. H.
    Neyman, G.
    Chao, S. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S10 - S11
  • [10] A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer
    Justin A. Chen
    Jasmine C. Huynh
    Chun-Yi Wu
    Ai-Ming Yu
    Karen Matsukuma
    Thomas J. Semrad
    David R. Gandara
    Tianhong Li
    Jonathan W. Riess
    Kit Tam
    Philip C. Mack
    Anthony Martinez
    Nichole Mahaffey
    Karen L. Kelly
    Edward J. Kim
    Cancer Chemotherapy and Pharmacology, 2022, 90 : 217 - 228
12345